Medistim ASA
OSE:MEDI
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
132
227
|
Price Target |
|
We'll email you a reminder when the closing price reaches NOK.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one MEDI stock under the Base Case scenario is 169.88 NOK. Compared to the current market price of 148 NOK, Medistim ASA is Undervalued by 13%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Medistim ASA
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for MEDI cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Economic Moat
Medistim ASA
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Medistim ASA
Balance Sheet Decomposition
Medistim ASA
Current Assets | 360.7m |
Cash & Short-Term Investments | 107.1m |
Receivables | 89.2m |
Other Current Assets | 164.4m |
Non-Current Assets | 116.2m |
PP&E | 59.4m |
Intangibles | 50.7m |
Other Non-Current Assets | 6.1m |
Current Liabilities | 81.7m |
Other Current Liabilities | 81.7m |
Non-Current Liabilities | 11.9m |
Long-Term Debt | 10.3m |
Other Non-Current Liabilities | 1.6m |
Earnings Waterfall
Medistim ASA
Revenue
|
538.4m
NOK
|
Cost of Revenue
|
-110.4m
NOK
|
Gross Profit
|
428m
NOK
|
Operating Expenses
|
-298.9m
NOK
|
Operating Income
|
129.1m
NOK
|
Other Expenses
|
-24.8m
NOK
|
Net Income
|
104.3m
NOK
|
Free Cash Flow Analysis
Medistim ASA
NOK | |
Free Cash Flow | NOK |
MEDI Profitability Score
Profitability Due Diligence
Medistim ASA's profitability score is 72/100. The higher the profitability score, the more profitable the company is.
Score
Medistim ASA's profitability score is 72/100. The higher the profitability score, the more profitable the company is.
MEDI Solvency Score
Solvency Due Diligence
Medistim ASA's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Score
Medistim ASA's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
MEDI Price Targets Summary
Medistim ASA
According to Wall Street analysts, the average 1-year price target for MEDI is 175.44 NOK with a low forecast of 173.72 NOK and a high forecast of 180.6 NOK.
Dividends
Current shareholder yield for MEDI is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Medistim ASA engages in the development, manufacturing, and distribution of medical equipment and consumables. The company is headquartered in Oslo, Oslo. The company went IPO on 2004-05-28. The company develops, manufactures and distributes medical devices primarily for cardiac and vascular surgery. The firm provides intra-operative standard control applications designed to verify and document quality during surgery. Its product portfolio comprises systems, such as ultrasound imaging systems VeriQ C and MiraQ, as well as probes, which offer Transit Time Flow Measurement (TTFM). The Company’s activities are divided into four business areas: lease of equipment within cardiac surgery, capital and consumable sales within cardiac surgery, sales of electronic stethoscopes and distribution and sales of third party products. Furthermore, the Company is a parent of Medistim USA Inc, Medistim Deutschland GmbH, and Medistim Norge AS, among others.
Officers
The intrinsic value of one MEDI stock under the Base Case scenario is 169.88 NOK.
Compared to the current market price of 148 NOK, Medistim ASA is Undervalued by 13%.